View company's website
San Francisco, US · 1 known investors
Nine Square Therapeutics develops drugs targeting neurodegenerative diseases, focusing on identifying and validating novel drug targets previously considered undruggable. The company combines experimental biology, computational methods, and systems-level approaches to advance treatments for conditions including Alzheimer's disease, Parkinson's disease, ALS, and frontotemporal lobar degeneration.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
L
Lani
S
Steve
MP
Matthew P. Jacobson
S
Spiros